{"title":"Pharmacological Haemodynamic Management in the Intensive Care Unit: The Evolution of the Nurse's Role Over 50 Years","authors":"Adrianna Lorraine Watson","doi":"10.1111/jan.70185","DOIUrl":null,"url":null,"abstract":"AimTo examine the evolution of intensive care nurses’ roles in pharmacological haemodynamic management from 1975 to 2025 and to explore projected responsibilities through 2075.DesignA scholarly commentary.MethodsA critical synthesis of literature, historical accounts and clinical guidelines spanning 1975–2025, focussing on nursing practice, technology, workforce dynamics and patient safety in critical care pharmacology.Data SourcesCINAHL, PubMed, EBSCO, Embase, Cochrane, Google Scholar and major pharmacological guideline repositories were searched for sources between 1975 and 2025, including clinical trials, systematic reviews, position papers and qualitative studies.ResultsNurses have progressed from unstandardised vasoactive medication titration to advanced, protocol‐driven multimodal vasopressor strategies. Milestones include the early catecholamine era, nurse‐led sepsis protocols and contemporary adoption of peripheral vasopressor practices supported by technology. Looking ahead, intensive care nurses will increasingly supervise technologically driven titration, manage multimodal regimens, address drug shortages and sustain resilience amid workforce pressures.ConclusionOver the past five decades, nurses have transformed vasopressor management and remain essential in bridging innovation with ethical, patient‐centred care. The next 50 years will require advanced decision‐making, technological fluency and improved support for the nursing workforce.Implications for the Profession and/or Patient CareInvestment in simulation‐based education, workforce supports and ethical frameworks is vital to prepare nurses for expanding responsibilities and ensure patient safety.ImpactProblem addressedHistorical variability and future challenges in nursing roles for vasopressor management.Main findingsNurses have driven safety and innovation and will face increasing technological, ethical and workforce demands.ImpactRelevant to critical care nurses, nurse educators, nurse leaders and policy‐makers worldwide shaping the future of critical care practice.","PeriodicalId":54897,"journal":{"name":"Journal of Advanced Nursing","volume":"23 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jan.70185","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
AimTo examine the evolution of intensive care nurses’ roles in pharmacological haemodynamic management from 1975 to 2025 and to explore projected responsibilities through 2075.DesignA scholarly commentary.MethodsA critical synthesis of literature, historical accounts and clinical guidelines spanning 1975–2025, focussing on nursing practice, technology, workforce dynamics and patient safety in critical care pharmacology.Data SourcesCINAHL, PubMed, EBSCO, Embase, Cochrane, Google Scholar and major pharmacological guideline repositories were searched for sources between 1975 and 2025, including clinical trials, systematic reviews, position papers and qualitative studies.ResultsNurses have progressed from unstandardised vasoactive medication titration to advanced, protocol‐driven multimodal vasopressor strategies. Milestones include the early catecholamine era, nurse‐led sepsis protocols and contemporary adoption of peripheral vasopressor practices supported by technology. Looking ahead, intensive care nurses will increasingly supervise technologically driven titration, manage multimodal regimens, address drug shortages and sustain resilience amid workforce pressures.ConclusionOver the past five decades, nurses have transformed vasopressor management and remain essential in bridging innovation with ethical, patient‐centred care. The next 50 years will require advanced decision‐making, technological fluency and improved support for the nursing workforce.Implications for the Profession and/or Patient CareInvestment in simulation‐based education, workforce supports and ethical frameworks is vital to prepare nurses for expanding responsibilities and ensure patient safety.ImpactProblem addressedHistorical variability and future challenges in nursing roles for vasopressor management.Main findingsNurses have driven safety and innovation and will face increasing technological, ethical and workforce demands.ImpactRelevant to critical care nurses, nurse educators, nurse leaders and policy‐makers worldwide shaping the future of critical care practice.
期刊介绍:
The Journal of Advanced Nursing (JAN) contributes to the advancement of evidence-based nursing, midwifery and healthcare by disseminating high quality research and scholarship of contemporary relevance and with potential to advance knowledge for practice, education, management or policy.
All JAN papers are required to have a sound scientific, evidential, theoretical or philosophical base and to be critical, questioning and scholarly in approach. As an international journal, JAN promotes diversity of research and scholarship in terms of culture, paradigm and healthcare context. For JAN’s worldwide readership, authors are expected to make clear the wider international relevance of their work and to demonstrate sensitivity to cultural considerations and differences.